About Us
Leo International Precision Health AG (“LIPH”) is a Frankfurt Stock Exchange-listed holding company building a global integrated AI-driven healthcare ecosystem. With a strategic focus on AI-driven precision healthcare assets across Biotech, MedTech, HealthTech and Healthcare Services, LIPH offers investors transparent access to the expanding Asian and global healthcare and life sciences market.
As LIPH continues to connect technology, care, and capital, it aims to deliver sustainable value creation for shareholders while shaping the future of intelligent, data-driven healthcare globally.
LIPH’s investment case is built on scalability, innovation, and synergy. By placing precision health at the core of its growth strategy and leveraging international capital markets to drive innovation, the company aims to increase shareholder value through asset reconfiguration, revenue growth, licensing and royalties.
Sustainability
As a healthcare company publicly listed in Germany, LIPH is committed to responsible, transparent, and sustainable value creation. Our mission to advance AI-driven precision healthcare naturally aligns with improving medical outcomes, increasing efficiency in care delivery, and supporting healthier societies.